GenoFocus (Korea) Analysis
| 187420 Stock | 4,050 165.00 3.91% |
GenoFocus is overvalued with Real Value of 3428.25 and Hype Value of 4050.0. The main objective of GenoFocus stock analysis is to determine its intrinsic value, which is an estimate of what GenoFocus is worth, separate from its market price. There are two main types of GenoFocus' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect GenoFocus' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of GenoFocus' stock to identify patterns and trends that may indicate its future price movements.
The GenoFocus stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GenoFocus' ongoing operational relationships across important fundamental and technical indicators.
GenoFocus |
GenoFocus Stock Analysis Notes
About 34.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. GenoFocus had 2:1 split on the 19th of March 2018. For more info on GenoFocus please contact the company at 82 4 2862 4483 or go to http://www.genofocus.com.GenoFocus Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GenoFocus' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GenoFocus or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| GenoFocus had very high historical volatility over the last 90 days | |
| The company reported the revenue of 25.87 B. Net Loss for the year was (8.53 B) with profit before overhead, payroll, taxes, and interest of 6.06 B. | |
| GenoFocus has accumulated about 25.11 B in cash with (2.39 B) of positive cash flow from operations. | |
| Roughly 34.0% of the company shares are owned by insiders or employees |
GenoFocus Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 132.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GenoFocus's market, we take the total number of its shares issued and multiply it by GenoFocus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.GenoFocus Profitablity
GenoFocus' profitability indicators refer to fundamental financial ratios that showcase GenoFocus' ability to generate income relative to its revenue or operating costs. If, let's say, GenoFocus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GenoFocus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GenoFocus' profitability requires more research than a typical breakdown of GenoFocus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.68) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.25. Technical Drivers
As of the 1st of December, GenoFocus retains the Market Risk Adjusted Performance of 4.17, downside deviation of 4.41, and Risk Adjusted Performance of 0.0725. GenoFocus technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.GenoFocus Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GenoFocus middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GenoFocus. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GenoFocus Outstanding Bonds
GenoFocus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GenoFocus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GenoFocus bonds can be classified according to their maturity, which is the date when GenoFocus has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
GenoFocus Predictive Daily Indicators
GenoFocus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GenoFocus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.044 | |||
| Daily Balance Of Power | (0.89) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 4112.5 | |||
| Day Typical Price | 4091.67 | |||
| Market Facilitation Index | 185.0 | |||
| Price Action Indicator | (145.00) | |||
| Period Momentum Indicator | (165.00) | |||
| Relative Strength Index | 55.54 |
GenoFocus Forecast Models
GenoFocus' time-series forecasting models are one of many GenoFocus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GenoFocus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding GenoFocus to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for GenoFocus Stock analysis
When running GenoFocus' price analysis, check to measure GenoFocus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenoFocus is operating at the current time. Most of GenoFocus' value examination focuses on studying past and present price action to predict the probability of GenoFocus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenoFocus' price. Additionally, you may evaluate how the addition of GenoFocus to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |